1. CB 1954 revisited

   • Paul Workman
   • Richard A. S. White
   • Kathleen Talbot

   Original Articles Pages: 1 - 8

2. CB 1954 revisited

   • Paul Workman
   • Jane E. Morgan
   • Peter R. Twentyman

   Original Articles Pages: 9 - 14

3. Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4′-O-methyldoxorubicin in tumor-bearing mice

   • Franca Formelli
   • Roberto Carsana
   • Carmen Pollini

   Original Articles Pages: 15 - 21

4. Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes

   • Aquilur Rahman
   • Angelo Fumagalli
   • Anna Maria Casazza

   Original Articles Pages: 22 - 27

5. Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes

   • Aquilur Rahman
   • Ali Ganjei
   • John R. Neefe

   Original Articles Pages: 28 - 34

6. Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane

   • Scott Rosenow
   • Kimberly L. Kooistra
   • Russell A. Van Dyke

   Original Articles Pages: 35 - 42

7. Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse

   • Garth Powis
   • Richard N. Harris
   • Kenneth S. Santone

   Original Articles Pages: 43 - 49

8. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance

   • Lewis M. Slater
   • Sandra L. Murray
   • Marie Stupecky

   Original Articles Pages: 50 - 54

9. Potentiation of antitumor activity of 1-phthalidyl 5-fluorouracil by acetazolamide

   • Hisanori Kasai
   • Kanya Tonda
   • Masaharu Hirata

   Original Articles Pages: 55 - 57

10. In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy

    • H.-Michael Runge
    • Günther Teufel
    • Albrecht Pfleiderer

    Original Articles Pages: 58 - 63

11. Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer

    • Antoine Thyss
    • Gérard Milano
    • François Demard

    Original Articles Pages: 64 - 66

12. A phase II study of bisantrene in malignant lymphomas

    • Thomas P. Miller
    • John D. Cowan
    • Stephen E. Jones

    Original Articles Pages: 67 - 69

13. Clinical pharmacology of vinzolidine

    • Willi Kreis
    • Daniel R Budman
    • Lydia Kevill

    Original Articles Pages: 70 - 74

14. Serum alpha fetoprotein kinetics in hepatocellular carcinoma

    • Paul K. Buamah
    • Andrew W. Skillen
    • A. Milford Ward

    Original Articles Pages: 75 - 77

15. Phase II study of 5′-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma

    • P. Alberto
    • M. Rozencweig
    • H. Pinedo

    Original Articles Pages: 78 - 79

16. Influence of clonogenic assay methodology on measurement of drug sensitivities in vitro

    • Peter J. Hepburn
    • John R. W. Masters

    Short Communication Pages: 80 - 82

17. The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the rat

    • Neil K. Burton
    • G. Wynne Aherne

    Short Communication Pages: 83 - 84